| scholarly article | Q13442814 |
| P50 | author | Chun-Ying Wu | Q73108712 |
| P2093 | author name string | Yi-Ju Chen | |
| Chuan-Mu Chen | |||
| Jui-Lung Shen | |||
| Yun-Ting Chang | |||
| Szu-Ying Chu | |||
| Chih-Kang Chen | |||
| P433 | issue | 12 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 1571-1575 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Archives of Dermatology | Q15749524 |
| P1476 | title | Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome | |
| P478 | volume | 144 |
| Q36801892 | Active Component of Danshen (Salvia miltiorrhiza Bunge), Tanshinone I, Attenuates Lung Tumorigenesis via Inhibitions of VEGF, Cyclin A, and Cyclin B Expressions |
| Q37831388 | Adipokines and psoriasis |
| Q38649854 | Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction. |
| Q37408380 | An observational study on the obesity and metabolic status of psoriasis patients |
| Q38673766 | An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies |
| Q35770123 | Analysis of cardiovascular risk factors and metabolic syndrome in korean patients with psoriasis |
| Q37588078 | Assessment of Leptin Gene Polymorphism rs2060713 in Psoriasis Vulgaris. |
| Q92462247 | Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis |
| Q59370664 | Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies. |
| Q38076496 | Cardiovascular aspects of psoriasis: an updated review |
| Q82734365 | Carotid intima-media thickness and serum leptin in psoriasis |
| Q43801124 | Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI. |
| Q38429390 | Co-morbidities in psoriasis: a hospital-based case-control study |
| Q44667616 | Curcumin reduces pulmonary tumorigenesis in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice |
| Q34346651 | Depression and the risk of psoriasis in US women |
| Q38446877 | Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis |
| Q35620533 | Effect of psoriasis activity on serum adiponectin and leptin levels. |
| Q26741784 | Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist |
| Q41330230 | Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis. |
| Q55347185 | Gene polymorphisms of TNF-238G/A, TNF-308G/A, IL10-1082G/A, TNFAIP3, and MC4R and comorbidity occurrence in a Romanian population with psoriasis. |
| Q89495120 | IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications |
| Q38310411 | Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. |
| Q45439220 | Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro--a possible reason for increased severity of psoriasis in patients with a high body mass index |
| Q34777416 | Leptin levels in patients with psoriasis: a meta-analysis |
| Q37734265 | Metabolic Syndrome in Psoriasis among Urban South Indians: A Case Control Study Using SAM-NCEP Criteria |
| Q93362774 | Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence |
| Q39248840 | Metabolic syndrome in Moroccan patients with psoriasis |
| Q39238988 | Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. |
| Q37778608 | Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation |
| Q37874647 | Obesity and the skin. |
| Q41515491 | Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital Study |
| Q51389843 | Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis |
| Q36352320 | Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study |
| Q37644609 | Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study |
| Q46180528 | Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment |
| Q41693144 | Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact? |
| Q35045850 | Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications |
| Q34418506 | Psoriasis and comorbidities: links and risks |
| Q37788777 | Psoriasis and non-alcoholic fatty liver disease. |
| Q37990043 | Psoriasis and physical activity: a review |
| Q37743164 | Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions |
| Q35168945 | Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature |
| Q37607422 | Psoriasis comorbidities |
| Q64073187 | Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls |
| Q38114903 | Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis |
| Q34348857 | Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis |
| Q35444953 | Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis |
| Q33627496 | Serum leptin and adiponectin levels in Korean patients with psoriasis. |
| Q38056160 | The association between psoriasis and dyslipidaemia: a systematic review |
| Q38064779 | The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies |
| Q37212524 | The effect of weight loss in obese patients with chronic stable plaque-type psoriasis |
| Q47644680 | The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis |
| Q51378426 | The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. |
| Q37955675 | The regulation of food intake in mammalian hibernators: a review |
| Q38845553 | The triad psoriasis-obesity-adipokine profile |
| Q30250110 | Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms |
| Q37929165 | Ustekinumab: a review of its use in the management of moderate to severe plaque psoriasis |
| Q34041797 | Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis |
Search more.